Abstract |
Neuroblastoma is a common childhood tumor comprising cases with rapid disease progression as well as spontaneous regression. Although numerous prognostic factors have been identified, risk evaluation in individual patients remains difficult. To define a reliable prognostic predictor and gene signatures characteristic of biological subgroups, we performed mRNA expression profiling of 68 neuroblastomas of all stages. Expression data were analysed using support vector machines (SVM-rbf), prediction analysis of microarrays (PAM), k-nearest neighbors (k-NN) algorithms and multiple decision trees. SVM-rbf performed best of all methods, and predicted recurrence of neuroblastoma with an accuracy of 85% (sensitivity 77%, specificity 94%). PAM identified a classifier of 39 genes reliably predicting outcome with an accuracy of 80%. In comparison, conventional risk stratification based on stage, age and MYCN-status only reached a predictive accuracy of 64%. Kaplan-Meier analysis using the PAM classifier indicated a 5-year survival of 20 versus 78% for patients with unfavorably versus favorably predicted neuroblastomas, respectively (P = 0.0001). Significance analysis of microarrays (SAM) identified additional genes differentially expressed among subgroups. MYCN-amplification and high expression of NTRK1/TrkA demonstrated a strong association with specific gene expression patterns. Our data suggest that microarray-derived data in addition to traditional clinical factors will be useful for risk assessment and defining biological properties of neuroblastoma.
|
Authors | Alexander Schramm, Johannes H Schulte, Ludger Klein-Hitpass, Werner Havers, Hauke Sieverts, Bernd Berwanger, Holger Christiansen, Patrick Warnat, Benedikt Brors, Jürgen Eils, Roland Eils, Angelika Eggert |
Journal | Oncogene
(Oncogene)
Vol. 24
Issue 53
Pg. 7902-12
(Nov 24 2005)
ISSN: 0950-9232 [Print] England |
PMID | 16103881
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- MYCN protein, human
- N-Myc Proto-Oncogene Protein
- Nuclear Proteins
- Oncogene Proteins
- RNA, Messenger
- Receptor, trkA
|
Topics |
- Algorithms
- Cohort Studies
- Decision Trees
- Gene Amplification
- Gene Expression Profiling
- Humans
- Infant
- Infant, Newborn
- N-Myc Proto-Oncogene Protein
- Neoplasm Staging
- Neuroblastoma
(genetics, pathology)
- Nuclear Proteins
(genetics)
- Oligonucleotide Array Sequence Analysis
- Oncogene Proteins
(genetics)
- Prognosis
- RNA, Messenger
(analysis)
- Receptor, trkA
(genetics)
- Risk Assessment
- Survival Analysis
|